COSMOS Pharmaceutical Corporation (TYO:3349)
Japan · Delayed Price · Currency is JPY 7,602.00
+178.00 (2.40%)
Nov 21, 2025, 3:30 PM JST
COSMOS Pharmaceutical Revenue
COSMOS Pharmaceutical had revenue of 272.39B JPY in the quarter ending August 31, 2025, with 4.03% growth. This brings the company's revenue in the last twelve months to 1.02T, up 3.73% year-over-year. In the fiscal year ending May 31, 2025, COSMOS Pharmaceutical had annual revenue of 1.01T with 4.81% growth.
Revenue (ttm)
1.02T
Revenue Growth
+3.73%
P/S Ratio
0.59
Revenue / Employee
179.01M
Employees
5,709
Market Cap
602.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 1.01T | 46.40B | 4.81% |
| May 31, 2024 | 964.99B | 137.29B | 16.59% |
| May 31, 2023 | 827.70B | 72.28B | 9.57% |
| May 31, 2022 | 755.41B | 28.99B | 3.99% |
| May 31, 2021 | 726.42B | 42.02B | 6.14% |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |